Literature DB >> 16781206

Fluorotoxic metabolic bone disease: an osteo-renal syndrome caused by excess fluoride ingestion in the tropics.

C V Harinarayan1, N Kochupillai, S V Madhu, N Gupta, P J Meunier.   

Abstract

BACKGROUND: There is scant data available on the pathogenetic mechanisms of varied clinical presentation of bone disease in patients with excess fluoride ingestion in the Indian subcontinent. The present study is comprehensive and state of the art, incorporating all essential elements of bone mineral metabolism in patients with excess fluoride ingestion.
METHODS: We studied 24 patients (age 31 +/- 16 years) with fluorotoxic metabolic bone disease (FMBD) for their clinical, radiological and biochemical parameters like serum calcium, phosphorous, alkaline phosphatase (SAP), 25-hydroxyvitamin D, 1,25 dihydroxyvitamin D, and parathyroid hormone levels, nephrologic parameters that assess renal handling of calcium and phosphorous and skeletal dynamics as revealed by bone histomorphometry.
FINDINGS: Major clinical manifestations were bone pain (79%), Tetany (12.5%) and dental mottling (38%). Radiological findings included osteosclerosis (96%), pseudofracture and ligamentous calcification (50%). These patients manifested hypocalcemia and raised SAP with normal serum phosphorus. There was a positive correlation between serum creatinine and phosphorous excretion index (PEI) and a negative correlation between declining endogenous creatinine clearance (Cr.Cl) and increasing renal loss of calcium and phosphorus as indicated by increased calcium to creatinine ratio and PEI. Bone histomorphometry revealed impairment of primary mineralization with hypomineralized lacunae, interstitial mineralization defects and very thick and extended osteoid seams. Autopsy findings in a patient who died of azotemia showed tubular atrophy with secondary glomerular changes.
INTERPRETATION: Fluoride intoxication plays an important role in the pathogenesis of the unique osteo-renal syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781206     DOI: 10.1016/j.bone.2006.04.021

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  10 in total

1.  Chronic kidney disease in two coastal districts of Andhra Pradesh, India: role of drinking water.

Authors:  D V Reddy; A Gunasekar
Journal:  Environ Geochem Health       Date:  2013-03-09       Impact factor: 4.609

2.  The effect of chronic treatment with fluoride on salivary activity, tooth, and bone in spontaneously hypertensive rats (SHR).

Authors:  Daniele C R Picco; Alberto C B Delbem; Kikue T Sassaki; Doris H Sumida; Cristina Antoniali
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-01-04       Impact factor: 3.000

3.  Skeletal fluorosis due to excessive tea and toothpaste consumption.

Authors:  S Joshi; T Hlaing; G M Whitford; J E Compston
Journal:  Osteoporos Int       Date:  2010-10-09       Impact factor: 4.507

4.  Effects of Fluoride on Bone in an Animal Model of Vitamin D Deficiency.

Authors:  Joseph Dian Bondu; M S Seshadri; R Selvakumar; Jude Joseph Fleming
Journal:  Indian J Clin Biochem       Date:  2017-11-13

5.  Fluoride Modulates Parathyroid Hormone Secretion in vivo and in vitro.

Authors:  Chaitanya P Puranik; Kathleen A Ryan; Zhaoyu Yin; E Angeles Martinez-Mier; John S Preisser; Eric T Everett
Journal:  Cells Tissues Organs       Date:  2015-09-19       Impact factor: 2.481

6.  Changes in serum seromucoid following compensatory hyperparathyroidism: A sequel to chronic fluoride ingestion.

Authors:  Sunil Kumar Gupta; R C Gupta; Kapil Gupta; H P Trivedi
Journal:  Indian J Clin Biochem       Date:  2008-06-11

Review 7.  Vitamin D deficiency in India: prevalence, causalities and interventions.

Authors:  Ritu G; Ajay Gupta
Journal:  Nutrients       Date:  2014-02-21       Impact factor: 5.717

8.  Black Tea Source, Production, and Consumption: Assessment of Health Risks of Fluoride Intake in New Zealand.

Authors:  Declan T Waugh; Michael Godfrey; Hardy Limeback; William Potter
Journal:  J Environ Public Health       Date:  2017-06-21

9.  Coexistence of two sclerotic bone diseases manifesting as spondyloarthropathy: Double trouble.

Authors:  Sanjay Kumar Bhadada; Soham Mukherjee; Prem Kumar; Anil Bhansali
Journal:  Bone Rep       Date:  2015-05-15

10.  Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide.

Authors:  Vishal Gupta
Journal:  Indian J Endocrinol Metab       Date:  2013-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.